Abstract

By means of various reactions the compound [TaCl3{N(SiMe3)2}2]1 has been converted into the following organoimido complexes: [{Ta(µ-Cl)Cl(NSiMe3)[N(SiMe3)2]}2]2, [{Ta(µ-I)I(NSiMe3)[N(SiMe3)2]}]4, [TaCl2(NSiMe3){N(SiMe3)2}(thf)]5(thf = tetrahydrofuran), [Ta(NEt)(NHEt){N(SiMe3)2}2]6 and [Ta(NBut)(NHEt){N(SiMe3)2}2]7. From 2 the compounds [Ta(NSiMe3){N(SiMe3)2}(NHBut)2]8, [Ta(NSiMe3){N(SiMe3)2}(OBut)2]9 and [{Ta(µ-OMe)(OMe)(NSiMe3)[N(SiMe3)2]}2]10 were obtained, and from [TaCl3(OC6H2MeBut2)2], [Ta(NEt)(NHEt)(OC6H2MeBut2)2]11, [Ta(NCH2But)(NHCH2But)(OC6H2MeBut2)2]12 and [Ta(NBut)(NHBut)(OC6H2MeBut2)2]13 were prepared. The compounds [TaCl3(NPh)(PEt3)2]14 and [TaCl3(NPh)(PEt2Ph)2]15 were prepared from reactions involving NHPh(SiMe3) and TaCl5 in the presence of the trialkylphosphine ligand. All of these new compounds have been characterized by NMR, IR and mass spectra and two of them, 2 and 10, have been structurally characterized by single-crystal X-ray crystallography.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.